Literature DB >> 22697205

A longitudinal investigation of the role of self-medication in the development of comorbid mood and drug use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Samuel Lazareck1, Jennifer A Robinson, Rosa M Crum, Ramin Mojtabai, Jitender Sareen, James M Bolton.   

Abstract

OBJECTIVE: To examine whether self-medication with drugs confers risk of comorbid mood and drug use disorders.
METHOD: A longitudinal, nationally representative survey was conducted by the National Institute on Alcohol Abuse and Alcoholism. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) assessed DSM-IV-TR psychiatric disorders, self-medication, and sociodemographic variables at 2 time points. A total of 34,653 adult, US participants completed both waves of the survey. Wave 1 was conducted between 2001 and 2002, and Wave 2 interviews took place 3 years later (2004-2005). Logistic regression and population attributable fractions were calculated to obtain estimates of the association between self-medication and incident disorders.
RESULTS: Logistic regression analyses revealed that self-medication with drugs conferred a heightened risk of new-onset drug dependence among those with baseline mood disorders (adjusted odds ratio [AOR] = 7.65; 95% CI, 3.70-15.82; P < .001) and accounted for over 25% of incident drug dependence disorders among people with mood disorders. Among those with comorbid mood and drug use disorders at baseline, self-medication with drugs was associated with the persistence of drug abuse (AOR = 2.47; 95% CI, 1.34-4.56; P < .01), accounting for over one-fifth of the persistence of drug use disorders at 3-year follow-up.
CONCLUSIONS: Self-medication with drugs among individuals with mood disorders confers substantial risk of developing incident drug dependence and is associated with the persistence of comorbid mood and drug use disorders. These results clarify a pathway that may lead to the development of mood and drug use disorder comorbidity and indicate an at-risk population, with potential points of intervention for prevention of comorbidity. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22697205      PMCID: PMC4151244          DOI: 10.4088/JCP.11m07345

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  28 in total

Review 1.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.

Authors:  H C Kraemer; E Stice; A Kazdin; D Offord; D Kupfer
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

2.  Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.

Authors:  F M Quitkin; A Rifkin; J Kaplan; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1972-08

Review 3.  The strong relationship between bipolar and substance-use disorder.

Authors:  Alan C Swann
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.

Authors:  Ron de Graaf; Rob V Bijl; Filip Smit; Wilma A M Vollebergh; J Spijker
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

5.  Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study.

Authors:  R V Bijl; A Ravelli
Journal:  Am J Public Health       Date:  2000-04       Impact factor: 9.308

6.  Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study.

Authors:  Kathleen Ries Merikangas; Heping Zhang; Shelli Avenevoli; Suddhasatta Acharyya; Martin Neuenschwander; Jules Angst
Journal:  Arch Gen Psychiatry       Date:  2003-10

7.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

8.  Does a U-shaped relationship exist between alcohol use and DSM-III-R mood and anxiety disorders?

Authors:  Jitender Sareen; Lachlan McWilliams; Brian Cox; Murray B Stein
Journal:  J Affect Disord       Date:  2004-10-01       Impact factor: 4.839

Review 9.  Exploring the association between cannabis use and depression.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Addiction       Date:  2003-11       Impact factor: 6.526

10.  Drinking to cope in socially anxious individuals: a controlled study.

Authors:  Suzanne E Thomas; Carrie L Randall; Maureen H Carrigan
Journal:  Alcohol Clin Exp Res       Date:  2003-12       Impact factor: 3.455

View more
  18 in total

1.  Pain interference and incident mood, anxiety, and substance-use disorders: findings from a representative sample of men and women in the general population.

Authors:  Declan T Barry; Corey E Pilver; Rani A Hoff; Marc N Potenza
Journal:  J Psychiatr Res       Date:  2013-08-27       Impact factor: 4.791

Review 2.  Affective vulnerability in substance use disorders.

Authors:  R Kathryn McHugh; Elizabeth T Kneeland
Journal:  Curr Opin Psychol       Date:  2019-01-28

3.  Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws.

Authors:  Aaron L Sarvet; Melanie M Wall; Katherine M Keyes; Mark Olfson; Magdalena Cerdá; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-03-02       Impact factor: 4.492

4.  Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders.

Authors:  Priscilla Martinez; Lars Lien; Sarah Zemore; Jørgen G Bramness; Sudan Prasad Neupane
Journal:  J Neuroimmunol       Date:  2018-02-22       Impact factor: 3.478

5.  Stress-related suppression of peripheral cytokines predicts future relapse in alcohol-dependent individuals with and without subclinical depression.

Authors:  Helen C Fox; Verica Milivojevic; Alicia MacDougall; Heather LaVallee; Christine Simpson; Gustavo A Angarita; Rajita Sinha
Journal:  Addict Biol       Date:  2019-11-17       Impact factor: 4.280

6.  Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort.

Authors:  Isaac C Rhew; Charles B Fleming; Ann Vander Stoep; Semret Nicodimos; Cheng Zheng; Elizabeth McCauley
Journal:  Addiction       Date:  2017-07-17       Impact factor: 6.526

Review 7.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

Review 8.  Postpartum substance use and depressive symptoms: a review.

Authors:  Shawna L Carroll Chapman; Li-Tzy Wu
Journal:  Women Health       Date:  2013

9.  Gender differences in the relationship between gambling problems and the incidence of substance-use disorders in a nationally representative population sample.

Authors:  Corey E Pilver; Daniel J Libby; Rani A Hoff; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2013-06-04       Impact factor: 4.492

10.  Association between posttraumatic stress disorder and nonfatal drug overdose.

Authors:  William K Lee; Kanna Hayashi; Kora DeBeck; M J S Milloy; Cameron Grant; Evan Wood; Thomas Kerr
Journal:  Psychol Trauma       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.